Herbert Goldstein

Array ( [id] => 8301891 [patent_doc_number] => 20120184454 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-07-19 [patent_title] => 'GENE SIGNATURE IS ASSOCIATED WITH EARLY STAGE RECTAL CANCER RECURRENCE' [patent_app_type] => utility [patent_app_number] => 13/351721 [patent_app_country] => US [patent_app_date] => 2012-01-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 9321 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13351721 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8094781 [patent_doc_number] => 20120082994 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-04-05 [patent_title] => 'Expression Levels of COL4A1 and other Markers Correlating with Progression or Non-Progression of Bladder Cancer' [patent_app_type] => utility [patent_app_number] => 13/316765 [patent_app_country] => US [patent_app_date] => 2011-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 11248 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20120082994.pdf [firstpage_image] =>[orig_patent_app_number] => 13316765 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8056031 [patent_doc_number] => 20120077703 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-29 [patent_title] => 'Expression of MBNL2 and Other Genes Associated with Bladder Cancer Progression' [patent_app_type] => utility [patent_app_number] => 13/323554 [patent_app_country] => US [patent_app_date] => 2011-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 52918 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0077/20120077703.pdf [firstpage_image] =>[orig_patent_app_number] => 13323554 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8821459 [patent_doc_number] => 20130122504 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-05-16 [patent_title] => 'Expression Levels of COL4A3BP and other Markers Correlating with Progression or Non-Progression of Bladder Cancer' [patent_app_type] => utility [patent_app_number] => 13/316733 [patent_app_country] => US [patent_app_date] => 2011-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 11244 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13316733 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8095665 [patent_doc_number] => 20120083424 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-04-05 [patent_title] => 'Expression of UBE2C and Other Genes Associated with Bladder Cancer Progression' [patent_app_type] => utility [patent_app_number] => 13/323273 [patent_app_country] => US [patent_app_date] => 2011-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 52984 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0083/20120083424.pdf [firstpage_image] =>[orig_patent_app_number] => 13323273 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11284019 [patent_doc_number] => 09499864 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-11-22 [patent_title] => 'Expression of FABP4 and other genes associated with bladder cancer progression' [patent_app_type] => utility [patent_app_number] => 13/316821 [patent_app_country] => US [patent_app_date] => 2011-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 12 [patent_no_of_words] => 52885 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 163 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13316821 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8196945 [patent_doc_number] => 20120121553 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-17 [patent_title] => 'SELECTION AND PROPAGATION OF PROGENITOR CELLS' [patent_app_type] => utility [patent_app_number] => 13/316169 [patent_app_country] => US [patent_app_date] => 2011-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 7951 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0121/20120121553.pdf [firstpage_image] =>[orig_patent_app_number] => 13316169 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8567307 [patent_doc_number] => 20120329878 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-12-27 [patent_title] => 'PHENOTYPING TUMOR-INFILTRATING LEUKOCYTES' [patent_app_type] => utility [patent_app_number] => 13/314072 [patent_app_country] => US [patent_app_date] => 2011-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 16872 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13314072 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8228335 [patent_doc_number] => 20120142543 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-06-07 [patent_title] => 'Methods to assess treatment outcomes in Reward Deficiency Syndrome (RDS)\nbehaviors utilizing expression profiling' [patent_app_type] => utility [patent_app_number] => 13/373774 [patent_app_country] => US [patent_app_date] => 2011-11-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 14763 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13373774 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7720842 [patent_doc_number] => 20120010177 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-12 [patent_title] => 'MicroRNA Modulators and Method for Identifying And Using The Same' [patent_app_type] => utility [patent_app_number] => 13/195169 [patent_app_country] => US [patent_app_date] => 2011-08-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 16807 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0010/20120010177.pdf [firstpage_image] =>[orig_patent_app_number] => 13195169 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8637153 [patent_doc_number] => 20130028956 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-01-31 [patent_title] => 'METHOD FOR PREVENTING OR TREATING MEMORY IMPAIRMENT AND PHARMACEUTICAL COMPOSITIONS USEFUL THEREFORE' [patent_app_type] => utility [patent_app_number] => 13/193841 [patent_app_country] => US [patent_app_date] => 2011-07-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 14161 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13193841 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11277322 [patent_doc_number] => 09493800 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-11-15 [patent_title] => 'Acyl amino acids' [patent_app_type] => utility [patent_app_number] => 13/186001 [patent_app_country] => US [patent_app_date] => 2011-07-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 17083 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 207 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13186001 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7733192 [patent_doc_number] => 20120015830 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-19 [patent_title] => 'MICRORNA PROFILES FOR EVALUATING MULTIPLE SCLEROSIS' [patent_app_type] => utility [patent_app_number] => 13/165492 [patent_app_country] => US [patent_app_date] => 2011-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 13720 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0015/20120015830.pdf [firstpage_image] =>[orig_patent_app_number] => 13165492 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7657247 [patent_doc_number] => 20110306516 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-15 [patent_title] => 'METHODS FOR PRODUCING INDUCED PLURIPOTENT STEM CELLS' [patent_app_type] => utility [patent_app_number] => 13/159030 [patent_app_country] => US [patent_app_date] => 2011-06-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 9763 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0306/20110306516.pdf [firstpage_image] =>[orig_patent_app_number] => 13159030 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8896519 [patent_doc_number] => 08476040 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-07-02 [patent_title] => 'Eukaryotic signal sequences for polypeptide expression and polypeptide display libraries' [patent_app_type] => utility [patent_app_number] => 13/112600 [patent_app_country] => US [patent_app_date] => 2011-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 27377 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 110 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13112600 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11873828 [patent_doc_number] => 09745587 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-08-29 [patent_title] => 'Nucleic acid constructs containing orthogonal site selective recombinases (OSSRs)' [patent_app_type] => utility [patent_app_number] => 13/088288 [patent_app_country] => US [patent_app_date] => 2011-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 21 [patent_no_of_words] => 12231 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 179 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13088288 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6113041 [patent_doc_number] => 20110190224 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-04 [patent_title] => 'Non-Viral Delivery of Compounds to Mitochondria' [patent_app_type] => utility [patent_app_number] => 13/082526 [patent_app_country] => US [patent_app_date] => 2011-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 15687 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0190/20110190224.pdf [firstpage_image] =>[orig_patent_app_number] => 13082526 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8063755 [patent_doc_number] => 20110245146 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-06 [patent_title] => 'Non-Viral Delivery of Compounds to Mitochondria' [patent_app_type] => utility [patent_app_number] => 13/082528 [patent_app_country] => US [patent_app_date] => 2011-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 15689 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0245/20110245146.pdf [firstpage_image] =>[orig_patent_app_number] => 13082528 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8065047 [patent_doc_number] => 20110244497 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-06 [patent_title] => 'METHOD FOR JUDGING SUSCEPTIBILITY OF CANCER CELLS TO ANTHRACYCLINE ANTICANCER AGENT AND COMPUTER PROGRAM' [patent_app_type] => utility [patent_app_number] => 13/075673 [patent_app_country] => US [patent_app_date] => 2011-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 11471 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0244/20110244497.pdf [firstpage_image] =>[orig_patent_app_number] => 13075673 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9704110 [patent_doc_number] => 08829173 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-09-09 [patent_title] => 'Recombinant vectors' [patent_app_type] => utility [patent_app_number] => 13/072704 [patent_app_country] => US [patent_app_date] => 2011-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 89 [patent_figures_cnt] => 80 [patent_no_of_words] => 47949 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 289 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13072704 [rel_patent_id] =>[rel_patent_doc_number] =>)